Brindisi Working to Rein in High Prescription Drug Prices
WASHINGTON – Rep. Anthony Brindisi, D-N.Y., knows the stories all too well.
Time and again during town halls and community events in his district, he’s heard the first-hand stories of hardworking families who’ve had to choose between paying for a loved one’s life-saving medicine and putting food on their table.
“I heard from one woman whose cancer medication cost $30,000 every few months,” the congressman told The Well News.
“This is unacceptable and highlights the fact that Congress needs to act,” Brindisi said.
The representative has proposed legislation to help bring down the overall cost of health care, general, and prescription drug costs, in particular.
Earlier this year, Brindisi reached across the aisle and worked with Republican Rep. John Joyce, of Pennsylvania, to introduce H.R. 2455, also known as the “Ensuring Timely Access to Generics Act.”
The bipartisan bill mandates steps the Food and Drug Administration can reduce the time it takes for generic drugs to come to market.
Brindisi’s legislation would give the agency the ability to deny petitions if the primary purpose of the petition is to delay the drug’s transition to the generic marketplace.
“I think we need to take a holistic and systemic approach to high drug prices in a way that lowers costs for patients and protects innovation,” he said, explaining his approach to the issue.
“I am supportive of many pieces of legislation that will get more affordable generic drugs to market, cap out-of-pocket costs for seniors, and provide stricter oversight of pharmaceutical companies and the middle-men who take a cut from patients,” Brindisi said.
“I wish this bill had more bipartisan buy-in and I am hopeful that my friends on the other side of the aisle will buy-in to some of these common-sense reforms,” he said.
Brindisi is co-chairman of the moderate Blue Dog Coalition, which last month endorsed and called on Congress to take up a series of prescription drug pricing bills that they believe, if taken up individually, could pass a Democratic-led House and a Republican-led Senate.
These included measures that would prohibit pharmaceutical companies from engaging in anti-competitive conduct that blocks lower-cost generic drugs from entering the market, and would reward manufacturers for challenging weak patents and bringing new generic drugs to market.
“The further left you go with drug pricing bills, it just means it’s only going to be a House-only bill and a Democrat-only bill,” Brindisi said at the time.
He also said he’s communicated that message to “to leadership and anyone who will listen around here.”
Of course, any action on prescription drug prices by the 116th Congress, will have to occur against the backdrop of impeachment and the looming presidential campaign.
Despites the odds against being able to reach both bipartisan and bicameral consensus on the issue, Brindisi said he is unbowed.
“I do think it is possible [to get this done],” he said. “Bringing down the cost of prescription drugs is an issue that goes beyond partisan politics. It might take a grand compromise between the House, the Senate, and the President, but the American people want this to get done and every elected official should be listening to their constituents.”
As for timing, Brindisi added confidently “there’s always time to get good, common-sense legislation done.”
“The simple fact is, Congress needs to act and work together to bring down costs. Bringing down the cost of prescription drugs is good policy which makes for good politics,” he said.
In The News
WASHINGTON - Rep. Kurt Schrader doesn't miss a chance to reach across the aisle if it will benefit his constituents. Among the most recent of multiple examples is the Oregon representative’s introduction of H.R. 4455, the Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act.... Read More
ATLANTA — The city of Marietta, Ga., has filed a class action lawsuit against a drug company after the price of a decades-old medicine went from $40 a vial to more than $39,000. The city, which covers health care costs for employees and their families, says... Read More
WASHINGTON -- Drug control experts urged Congress Tuesday to take quick action to prevent drugs created by clandestine chemists that mimic the effects of opioids from entering legal and illegal marketplaces. They suggested that Congress turn a temporary order on the chemicals into a permanent prohibition... Read More
WASHINGTON — In an election year when nobody expects Congress to pass meaningful legislation, lawmakers are feeling strong political pressure to reach a deal on at least one main voter priority: lowering drug prices. The most likely result could be a small deal that caps out-of-pocket... Read More
WASHINGTON - Rep. Kendra Horn believes it should come as no surprise to anyone that reining in runaway prescription drug prices has been a top priority of members of the 116th Congress. "After all, they are something that impacts just about everyone at some point in... Read More
WASHINGTON - In the Lowcountry of South Carolina, Rep. Joe Cunningham's race for Congress quickly became the stuff of local legend. Here was a first-time candidate, a Democrat running in a staunchly Republican district, who defeated a well-financed GOP opponent, to become the first Democratic representative... Read More